Should any of those matters you mention affect Amarin share price, considering the CVD market Vascepa seems destined to fill? Or do you think Amarin shares will simply be carried along with the ebb tide that Dalio and like peers envision? Do you assume ROKU, NVDA, AMD would be similarly affected in the negative manner you portray?
You mention Nickel used in LI battery production—what about Cobalt(said to improve making/working of Li batteries) and the Canadian company that is working to open an additional cobalt-laden mine in Idaho that seems closer to Nevada(TSLA battery plant) than the African mine facilities operated by Glencore? Notice who Glencore is now collaborating with?
Amarin has already partnered with a Canadian company as well as Eddingpharm in China to bring V to market sooner— will those markets not assist to keep Amarin share price steady or increase further?
Market Data 
Markets 
AI
